menu
    • menu

    Company profile for Context Therapeutics

    NEW Drugs in Dev: 4
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Context Therapeutics is a clinical-stage biopharmaceutical company dedicated to creating new medicines to treat hormone-responsive cancers. Context’s lead program is Apristor (Onapristone XR), an investigational Phase 2 drug that is being developed for progesterone receptor positive (PR+) metastatic breast and ovarian cancers. In addition, Context is advancing CTX-030916, a potential best-in-class oral antiprogestin for the ...
    Context Therapeutics is a clinical-stage biopharmaceutical company dedicated to creating new medicines to treat hormone-responsive cancers. Context’s lead program is Apristor (Onapristone XR), an investigational Phase 2 drug that is being developed for progesterone receptor positive (PR+) metastatic breast and ovarian cancers. In addition, Context is advancing CTX-030916, a potential best-in-class oral antiprogestin for the treatment of uterine fibroids and endometriosis, and a discovery-stage program targeting Sigma1

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Context TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3675 Market Street, Suite 200 Philadelphia, PA 19104
    Telephone
    Telephone
    267.225.7416
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.contexttherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/context-therapeutics
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/Context_Tx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AACR Annual meeting

    AACR Annual meeting

    Not Confirmed

    envelop Contact Supplier

    AACR Annual meeting

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Context Therapeutics Reports 2025 Financial Results
    Context Therapeutics Reports 2025 Financial Results

    23 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/23/3260846/0/en/Context-Therapeutics-Reports-Full-Year-2025-Operating-and-Financial-Results.html

    GLOBENEWSWIRE
    23 Mar 2026
    Share Share
    Context Therapeutics Presents Poster At AACR Annual Meeting 2026
    Context Therapeutics Presents Poster At AACR Annual Meeting 2026

    19 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/19/3258889/0/en/Context-Therapeutics-Announces-Poster-Presentation-at-the-American-Association-for-Cancer-Research-AACR-Annual-Meeting-2026.html

    GLOBENEWSWIRE
    19 Mar 2026
    Share Share
    Context Therapeutics Joins Investor Conferences
    Context Therapeutics Joins Investor Conferences

    09 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/09/3234427/0/en/Context-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences.html

    GLOBENEWSWIRE
    09 Feb 2026
    Share Share
    Context Announces Inducement Grants Under Nasdaq LR 5635(c)(4)
    Context Announces Inducement Grants Under Nasdaq LR 5635(c)(4)

    16 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/16/3220552/0/en/Context-Therapeutics-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    16 Jan 2026
    Share Share
    Context Therapeutics Showcases CT-95 And CT-202 Programs at SITC
    Context Therapeutics Showcases CT-95 And CT-202 Programs at SITC

    07 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/07/3183563/0/en/Context-Therapeutics-Highlights-CT-95-and-CT-202-Programs-at-2025-SITC-Annual-Meeting.html

    GLOBENEWSWIRE
    07 Nov 2025
    Share Share
    Context Therapeutics Reports Q3 2025 Operating & Financial
    Context Therapeutics Reports Q3 2025 Operating & Financial

    05 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/05/3182001/0/en/Context-Therapeutics-Reports-Third-Quarter-2025-Operating-and-Financial-Results.html

    GLOBENEWSWIRE
    05 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search